Cargando…
Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection
A 32-year-old woman with a history of symptomatic supraventricular tachycardia, inappropriate sinus tachycardia, and hyperadrenergic POTS was treated with ivabradine and metoprolol. She then presented with bradycardia and Mobitz II second-degree AV block on event monitoring six weeks after COVID-19...
Autores principales: | Ocher, Rebecca A., Padilla, Erika, Hsu, Jonathan C., Taub, Pam R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405341/ https://www.ncbi.nlm.nih.gov/pubmed/34471549 http://dx.doi.org/10.1155/2021/7809231 |
Ejemplares similares
-
Postural orthostatic tachycardia syndrome as a sequela of COVID-19
por: Ormiston, Cameron K., et al.
Publicado: (2022) -
Low-level tragus stimulation improves autoantibody-induced hyperadrenergic postural tachycardia syndrome in rabbits
por: Guo, Yankai, et al.
Publicado: (2022) -
Long-Term Outcomes of Hyperadrenergic Orthostatic Hypotension
por: Castro, Robert Alexander, et al.
Publicado: (2023) -
Post-Concussive Orthostatic Tachycardia is Distinct from Postural
Orthostatic Tachycardia Syndrome (POTS) in Children and
Adolescents
por: Pearson, Rachel, et al.
Publicado: (2022) -
May-Thurner syndrome in patients with postural orthostatic
tachycardia syndrome and Ehlers-Danlos syndrome: a case series
por: Ormiston, Cameron K., et al.
Publicado: (2022)